BRAF is known as a common mutated kinase in various human cancer types [46,50,53] including melanoma [50,54], colorectal cancer [55], thyroid cancer [56], non-small-cell lung cancer (NSCLC) [57,58], hairy cell leukemia [59], and primary CNS tumors [48]. This evidence concerns the gene BRAF and cancer.